Angela Blount v. United of Omaha Life Ins Co , 690 F. App'x 908 ( 2017 )


Menu:
  •                NOT RECOMMENDED FOR FULL-TEXT PUBLICATION
    File Name: 17a0386n.06
    No. 16-6372
    FILED
    UNITED STATES COURT OF APPEALS                         Jun 30, 2017
    FOR THE SIXTH CIRCUIT                         DEBORAH S. HUNT, Clerk
    ANGELA BLOUNT,                                          )
    )
    Plaintiff-Appellant,                             )
    )
    v.                                                      )       ON APPEAL FROM THE
    )       UNITED STATES DISTRICT
    UNITED OF OMAHA LIFE INSURANCE                          )       COURT FOR THE MIDDLE
    COMPANY,                                                )       DISTRICT OF TENNESSEE
    )
    Defendant-Appellee.                              )
    )
    BEFORE:        GIBBONS, ROGERS, and DONALD, Circuit Judges.
    ROGERS, Circuit Judge. In this ERISA case, plaintiff Angela Blount challenges the
    denial of long-term disability benefits by defendant United of Omaha Life Insurance Company,
    which relied on plan language limiting such benefits where a disability is caused by drug or
    substance abuse. Blount contends that the plan language does not apply in the case of opioids
    taken pursuant to her doctor’s prescription. The district court, however, properly determined that
    United of Omaha did not abuse its discretion in interpreting the plan language.
    United of Omaha—the relevant plan administrator—began paying Blount long-term
    disability benefits on the basis of her treating rheumatologist’s diagnosis of pain, fatigue, and
    cognitive problems associated with lupus and fibromyalgia.        However, subsequent treating
    physicians and independent medical experts expressed doubt with the initial diagnosis and
    opinion, instead attributing Blount’s disabling fatigue and cognitive problems to her “massive”
    No. 16-6372
    Angela Blount v. United of Omaha Life Insurance Company
    prescription opioid regimen for lupus and fibromyalgia. On the basis of these later medical
    opinions, United of Omaha determined that Blount was disabled due only to the effects of her
    opioid regimen—not lupus and fibromyalgia—and invoked a provision in her plan that limited
    benefits to 24 months when the disability was due to “substance abuse,” i.e., “any condition or
    disease, regardless of its cause, listed in the most recent edition of the International Classification
    of Diseases as a mental disorder.”          Within 24 months, Blount had exhausted all her
    administrative remedies within United of Omaha’s claims and appeals procedures and her
    benefits were terminated.
    Blount then brought suit in the Middle District of Tennessee under the civil enforcement
    provision of the Employee Retirement Income Security Act (ERISA). See 
    29 U.S.C. § 1132
    .
    Both Blount and United of Omaha moved for judgment on the administrative record. The district
    court granted United of Omaha’s motion but denied Blount’s, reasoning that there was
    substantial evidence in the record to support United of Omaha’s determination that Blount was
    disabled due to her opioid regimen, and that it was neither arbitrary nor capricious for United of
    Omaha to invoke the 24-month substance abuse limitation in Blount’s plan once it determined
    that Blount’s disability was due to her opioid regimen. Blount v. United of Omaha Life Ins. Co.,
    No. 3:15-CV-00876, 
    2016 WL 4191725
     (M.D. Tenn. Aug. 8, 2016). Blount now appeals.
    After carefully reviewing the record, the applicable law, and the parties’ briefs, we
    conclude that the district court’s opinion correctly sets out the facts and governing law. Because
    this court’s issuance of a full opinion would serve no jurisprudential purpose and would be
    duplicative, we affirm on the basis of the well-reasoned opinion of the district court.
    -2-
    

Document Info

Docket Number: 16-6372

Citation Numbers: 690 F. App'x 908

Filed Date: 6/30/2017

Precedential Status: Non-Precedential

Modified Date: 1/13/2023